Related Experiment Videos
Which drugs can be used during pregnancy?
Duodecim; Laaketieteellinen Aikakauskirja
|December 1, 2017
Summary
Drug therapy decisions during pregnancy often lack evidence. Revising medication during pregnancy planning is crucial for fetal safety, prioritizing drugs with known safety profiles.
Area of Science:
- Pharmacology
- Obstetrics
- Teratology
Background:
- Drug therapy decisions during pregnancy frequently lack evidence-based information on safety and effectiveness.
- While some drugs are known teratogens, evidence is insufficient for most medications.
- Fetal organogenesis occurs early, necessitating medication review during pregnancy planning.
Purpose of the Study:
- To highlight the challenges in evidence-based drug therapy during pregnancy.
- To emphasize the importance of pre-conception medication review.
- To guide the selection of safer medications for pregnant individuals.
Main Methods:
- Literature review on drug safety in pregnancy.
- Analysis of existing data on teratogenicity.
- Clinical guidelines for medication use during gestation.
Main Results:
- Limited evidence exists for the safety and efficacy of many drugs used in pregnancy.
- The majority of drugs lack sufficient data for comprehensive risk assessment.
- Early pregnancy is a critical period for fetal development, making medication choices paramount.
Conclusions:
- Medication management during pregnancy requires careful consideration due to data limitations.
- Prioritizing drugs with established safety records in pregnancy is essential.
- Proactive medication review before and during pregnancy planning is critical for fetal well-being.